Indication
Otorhinolaryngologic Diseases
2 clinical trials
2 products
Clinical trial
A Phase I/II, Open-ended, Adaptative, Open Label Dose Escalation and Expansion Clinical Trial to Evaluate the Efficacy and Safety of Unilateral Intracochlear Injection of SENS-501 Using an Injection System in Children With Severe to Profound Hearing Loss Due to Otoferlin Gene MutationsStatus: Not yet recruiting, Estimated PCD: 2027-04-01
Product
SENS-501Clinical trial
Impact of Spa Treatments on the Consumption of Care in ChildrenStatus: Completed, Estimated PCD: 2022-12-31
Product
Drug consumption